Acumen Pharmaceuticals, Inc.
NASDAQ:ABOS
3.17 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -52.371 | -42.856 | -100.606 | -7.325 | -7.907 |
| Depreciation & Amortization
| 0.184 | 0.169 | 0.004 | 0 | 0 |
| Deferred Income Tax
| -6.774 | 0 | 0.155 | 0 | 0 |
| Stock Based Compensation
| 6.145 | 3.061 | 0.922 | 0.154 | 0.174 |
| Change In Working Capital
| 3.866 | 3.986 | 0.298 | 0.307 | 0.768 |
| Accounts Receivables
| 0 | 0 | 0 | -0.079 | 0.2 |
| Inventory
| 0 | 0 | 0 | 0.079 | -0.2 |
| Accounts Payables
| -0.261 | 0.552 | 0.557 | 0.308 | 0.11 |
| Other Working Capital
| 4.127 | 3.434 | -0.259 | -0.001 | 0.658 |
| Other Non Cash Items
| 5.886 | 0.487 | 81.266 | -0.586 | 0.147 |
| Operating Cash Flow
| -43.064 | -35.153 | -17.961 | -7.45 | -6.818 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.021 | -0.161 | -0.04 | 0 | 0 |
| Acquisitions Net
| 0.003 | -0.039 | 0 | 0 | 0 |
| Purchases Of Investments
| -250.634 | -41.514 | -104.08 | 0 | 0 |
| Sales Maturities Of Investments
| 78.981 | 80.86 | 0 | 0 | 0 |
| Other Investing Activites
| -0.172 | 0.039 | -0.104 | 0 | 0 |
| Investing Cash Flow
| -171.671 | 39.185 | -104.12 | 0 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| -29.524 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 122.229 | 3.907 | 200.466 | 44.675 | 6.239 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 59.048 | 3.907 | 200.466 | 0.045 | 0.006 |
| Financing Cash Flow
| 151.753 | 3.907 | 200.466 | 44.675 | 6.239 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| -0.233 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -63.215 | 7.939 | 78.385 | 37.225 | -0.579 |
| Cash At End Of Period
| 66.886 | 130.101 | 122.162 | 43.777 | 6.552 |